دورية أكاديمية

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

التفاصيل البيبلوغرافية
العنوان: A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer
المؤلفون: Spetsieris, Nicholas, Boukovala, Myrto, Weldon, Justin A., Tsikkinis, Alexandros, Hoang, Anh, Aparicio, Ana, Tu, Shi-Ming, Araujo, John C., Zurita, Amado J., Corn, Paul G., Pagliaro, Lance, Kim, Jeri, Wang, Jennifer, Subudhi, Sumit K., Tannir, Nizar M., Logothetis, Christopher J., Troncoso, Patricia, Wang, Xuemei, Wen, Sijin, Efstathiou, Eleni
المصدر: In Clinical Genitourinary Cancer February 2021 19(1):22-31
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15587673
DOI:10.1016/j.clgc.2020.05.013